|
1
|
Madsen P, Rasmussen HH, Leffers H, Honoré
B, Dejgaard K, Olsen E, Kiil J, Walbum E, Andersen AH, Basse B, et
al: Molecular cloning, occurrence, and expression of a novel
partially secreted protein “psoriasin” that is highly up-regulated
in psoriatic skin. J Invest Dermatol. 97:701–712. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hoffmann HJ, Olsen E, Etzerodt M, Madsen
P, Thøgersen HC, Kruse T and Celis JE: Psoriasin binds calcium and
is upregulated by calcium to levels that resemble those observed in
normal skin. J Invest Dermatol. 103:370–375. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Børglum AD, Flint T, Madsen P, Celis JE
and Kruse TA: Refined mapping of the psoriasin gene S100A7 to
chromosome 1cen-q21. Hum Genet. 96:592–596. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Schäfer BW and Heizmann CW: The S100
family of EF-hand calcium-binding proteins: Functions and
pathology. Trends Biochem Sci. 21:134–140. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wolf R, Howard OM, Dong H-F, Voscopoulos
C, Boeshans K, Winston J, Divi R, Gunsior M, Goldsmith P, Ahvazi B,
et al: Chemotactic activity of S100A7 (Psoriasin) is mediated by
the receptor for advanced glycation end products and potentiates
inflammation with highly homologous but functionally distinct
S100A15. J Immunol. 181:1499–1506. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Boniface K, Bernard FX, Garcia M, Gurney
AL, Lecron JC and Morel F: IL-22 inhibits epidermal differentiation
and induces proinflammatory gene expression and migration of human
keratinocytes. J Immunol. 174:3695–3702. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Boniface K, Diveu C, Morel F, Pedretti N,
Froger J, Ravon E, Garcia M, Venereau E, Preisser L, Guignouard E,
et al: Oncostatin M secreted by skin infiltrating T lymphocytes is
a potent keratinocyte activator involved in skin inflammation. J
Immunol. 178:4615–4622. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gläser R, Harder J, Lange H, Bartels J,
Christophers E and Schröder JM: Antimicrobial psoriasin (S100A7)
protects human skin from Escherichia coli infection. Nat Immunol.
6:57–64. 2005. View
Article : Google Scholar
|
|
9
|
Jinquan T, Vorum H, Larsen CG, Madsen P,
Rasmussen HH, Gesser B, Etzerodt M, Honoré B, Celis JE and
Thestrup-Pedersen K: Psoriasin: A novel chemotactic protein. J
Invest Dermatol. 107:5–10. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jiang WG, Watkins G, Douglas-Jones A and
Mansel RE: Psoriasin is aberrantly expressed in human breast cancer
and is related to clinical outcomes. Int J Oncol. 25:81–85.
2004.PubMed/NCBI
|
|
11
|
Ye L, Sun PH, Martin TA, Sanders AJ, Mason
MD and Jiang WG: Psoriasin (S100A7) is a positive regulator of
survival and invasion of prostate cancer cells. Urol Oncol.
31:1576–1583. 2013. View Article : Google Scholar
|
|
12
|
Moubayed N, Weichenthal M, Harder J,
Wandel E, Sticherling M and Gläser R: Psoriasin (S100A7) is
significantly up-regulated in human epithelial skin tumours. J
Cancer Res Clin Oncol. 133:253–261. 2007. View Article : Google Scholar
|
|
13
|
Tripathi SC, Matta A, Kaur J, Grigull J,
Chauhan SS, Thakar A, Shukla NK, Duggal R, DattaGupta S, Ralhan R,
et al: Nuclear S100A7 is associated with poor prognosis in head and
neck cancer. PLoS One. 5:e119392010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Celis JE, Rasmussen HH, Vorum H, Madsen P,
Honoré B, Wolf H and Orntoft TF: Bladder squamous cell carcinomas
express psoriasin and externalize it to the urine. J Urol.
155:2105–2112. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hu M, Ye L, Ruge F, Zhi X, Zhang L and
Jiang WG: The clinical significance of Psoriasin for non-small cell
lung cancer patients and its biological impact on lung cancer cell
functions. BMC Cancer. 12:5882012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Enerbäck C, Porter DA, Seth P, Sgroi D,
Gaudet J, Weremowicz S, Morton CC, Schnitt S, Pitts RL, Stampl J,
et al: Psoriasin expression in mammary epithelial cells in vitro
and in vivo. Cancer Res. 62:43–47. 2002.PubMed/NCBI
|
|
17
|
Emberley ED, Alowami S, Snell L, Murphy LC
and Watson PH: S100A7 (psoriasin) expression is associated with
aggressive features and alteration of Jab1 in ductal carcinoma in
situ of the breast. Breast Cancer Res. 6:R308–R315. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Watson PH, Leygue ER and Murphy LC:
Psoriasin (S100A7). Int J Biochem Cell Biol. 30:567–571. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shubbar E, Vegfors J, Carlström M,
Petersson S and Enerbäck C: Psoriasin (S100A7) increases the
expression of ROS and VEGF and acts through RAGE to promote
endothelial cell proliferation. Breast Cancer Res Treat. 134:71–80.
2012. View Article : Google Scholar
|
|
20
|
Sneh A, Deol YS, Ganju A, Shilo K, Rosol
TJ, Nasser MW and Ganju RK: Differential role of psoriasin (S100A7)
in estrogen receptor α positive and negative breast cancer cells
occur through actin remodeling. Breast Cancer Res Treat.
138:727–739. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jemal A, Siegel R, Ward E, Hao Y, Xu J and
Thun MJ: Cancer statistics, 2009. CA Cancer J Clin. 59:225–249.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gadiya M, Mori N, Cao MD, Mironchik Y,
Kakkad S, Gribbestad IS, Glunde K, Krishnamachary B and Bhujwalla
ZM: Phospholipase D1 and choline kinase-α are interactive targets
in breast cancer. Cancer Biol Ther. 15:593–601. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zuker M: Mfold web server for nucleic acid
folding and hybridization prediction. Nucleic Acids Res.
31:3406–3415. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bonnekoh B, Wevers A, Jugert F, Merk H and
Mahrle G: Colorimetric growth assay for epidermal cell cultures by
their crystal violet binding capacity. Arch Dermatol Res.
281:487–490. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Moffitt RA, Marayati R, Flate EL, Volmar
KE, Loeza SG, Hoadley KA, Rashid NU, Williams LA, Eaton SC, Chung
AH, et al: Virtual microdissection identifies distinct tumor- and
stroma-specific subtypes of pancreatic ductal adenocarcinoma. Nat
Genet. 47:1168–1178. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang G, He P, Tan H, Budhu A, Gaedcke J,
Ghadimi BM, Ried T, Yfantis HG, Lee DH, Maitra A, et al:
Integration of metabolomics and transcriptomics revealed a fatty
acid network exerting growth inhibitory effects in human pancreatic
cancer. Clin Cancer Res. 19:4983–4993. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Deer EL, González-Hernández J, Coursen JD,
Shea JE, Ngatia J, Scaife CL, Firpo MA and Mulvihill SJ: Phenotype
and genotype of pancreatic cancer cell lines. Pancreas. 39:425–435.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Emberley ED, Niu Y, Leygue E, Tomes L,
Gietz RD, Murphy LC and Watson PH: Psoriasin interacts with Jab1
and influences breast cancer progression. Cancer Res. 63:1954–1961.
2003.PubMed/NCBI
|
|
29
|
Tomoda K, Kubota Y and Kato J: Degradation
of the cyclin-dependent-kinase inhibitor p27Kip1 is
instigated by Jab1. Nature. 398:160–165. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sgambato A, Cittadini A, Faraglia B and
Weinstein IB: Multiple functions of p27(Kip1) and its alterations
in tumor cells: A review. J Cell Physiol. 183:18–27. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ellenrieder V, Alber B, Lacher U, Hendler
SF, Menke A, Boeck W, Wagner M, Wilda M, Friess H, Büchler M, et
al: Role of MT-MMPs and MMP-2 in pancreatic cancer progression. Int
J Cancer. 85:14–20. 2000. View Article : Google Scholar
|
|
32
|
Zhang K, Chen D, Jiao X, Zhang S, Liu X,
Cao J, Wu L and Wang D: Slug enhances invasion ability of
pancreatic cancer cells through upregulation of matrix
metalloproteinase-9 and actin cytoskeleton remodeling. Lab Invest.
91:426–438. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Morgan MR, Jazayeri M, Ramsay AG, Thomas
GJ, Boulanger MJ, Hart IR and Marshall JF: Psoriasin (S100A7)
associates with integrin β6 subunit and is required for
αvβ6-dependent carcinoma cell invasion. Oncogene. 30:1422–1435.
2011. View Article : Google Scholar
|
|
34
|
Dey KK, Sarkar S, Pal I, Das S, Dey G,
Bharti R, Banik P, Roy J, Maity S, Kulavi I, et al: Mechanistic
attributes of S100A7 (psoriasin) in resistance of anoikis resulting
tumor progression in squamous cell carcinoma of the oral cavity.
Cancer Cell Int. 15:742015. View Article : Google Scholar : PubMed/NCBI
|
